Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1212.20Today’s High
1237.8052W low
667.8052W High
1259.40Open Price
1228.00Prev. Close
1033.7500Volume
760235.00Value
924369736.50Fundamentals
Market Cap Cr
21778.00
Price to Earnings
15.70
Price to Book Value
3.70
Dividend Yield
0.80
PE to Growth
0.20
Op Revenue TTM Cr
3998.80
Net Profit TTM Cr
1388.30
Cash From Operating Activity Cr
1211.60
Return on Equity %
23.71
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
57.8
Week
50.5
Month
49.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1221.95
PIVOT
First Resistance
1231.75
Second Resistance
1247.60
Third Resistance
1257.40
First Support
1206.10
Second Support
1196.30
Third Support
1180.45
Relative Strength Index
66.83
Money Flow Index
76.81
MACD
40.54
MACD Signal
41.92
Average True Range
40.55
Average Directional Index
41.59
Rate of Change (21)
25.31
Rate of Change (125)
48.13
Commodity Channel Index
98.9
Williams %R
-38
BETA
1 Month
0.77
3 Month
0.58
1 Year
0.55
3 Year
0.33
PRICE CHANGE ANALYSIS
↑ 3.21%
1 Week
Low
High
1145
1239
↑ 21.55%
1 Month
Low
High
952
1259.45
↑ 21.82%
3 Months
Low
High
950.55
1259.45
↑ 45.54%
6 Months
Low
High
805
1259.45
↑ 75.2%
1 Year
Low
High
667.8
1259.45
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1000.70 | 654.80 | 955.20 | 1062.90 | 798.70 | 431.60 | 367.30 | 838.90 | 524.50 | 561.10 | 370.70 | |
| Operating Expenses Qtr | 512.10 | 387.00 | 488.20 | 544.60 | 453.50 | 345.50 | 281.00 | 426.30 | 551.80 | 441.80 | 281.00 | |
| Operating Profit Qtr | 452.70 | 238.30 | 442.30 | 503.70 | 327.70 | 67.50 | 70.10 | 379.40 | -37.70 | 87.70 | 49.40 | |
| EBIDT Qtr Cr | 488.60 | 267.80 | 467.00 | 518.30 | 345.20 | 86.10 | 86.30 | 412.60 | -27.30 | 119.30 | 89.70 | |
| Depreciation Qtr | 51.60 | 40.40 | 40.00 | 39.90 | 37.60 | 38.10 | 38.30 | 36.90 | 35.60 | 35.50 | 34.20 | |
| Net Profit Qtr | 349.10 | 192.00 | 360.20 | 405.30 | 254.10 | 37.30 | 37.70 | 308.00 | -61.30 | 71.60 | 53.60 | |
| Basic EPS Qtr | 19.49 | 10.72 | 20.11 | 22.43 | 13.92 | 2.04 | 2.07 | 16.87 | -3.36 | 3.93 | 2.94 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 3673.60 | 2436.50 | 1862.40 | 1754.60 | 1914.00 | |
| Operating Expenses Annual Cr | 1931.90 | 1506.30 | 1554.80 | 1235.90 | 1212.20 | |
| Operating Profit Annual | 1637.00 | 844.70 | 213.00 | 417.60 | 578.00 | |
| Operating Profit Margin Annual % | 44.56 | 34.67 | 11.44 | 23.80 | 30.20 | |
| Total Expenses Annual Cr | 2118.30 | 1665.80 | 1706.50 | 1362.40 | 1330.90 | |
| EBIDT Annual Cr | 1741.70 | 930.20 | 307.60 | 518.70 | 701.80 | |
| EBIDT Annual margin % | 47.41 | 38.18 | 16.52 | 29.56 | 36.67 | |
| Depreciation | 171.90 | 150.90 | 138.40 | 115.20 | 98.10 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1306.60 | 637.10 | 139.10 | 309.50 | 474.50 | |
| Net Profit Annual | 1306.60 | 637.10 | 139.10 | 309.50 | 474.50 | |
| Basic EPS Annual | 72.79 | 34.90 | 7.63 | 16.99 | 26.08 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 5592.30 | 4702.00 | 4191.90 | 4091.10 | 3869.50 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 76.10 | 116.90 | 134.90 | 142.90 | 117.50 | |
| Total Current Liabilities Annual Cr | 885.60 | 569.00 | 651.20 | 518.50 | 659.70 | |
| Total Capital Plus Liabilities Annual Cr | 6554.00 | 5387.90 | 4978.00 | 4752.50 | 4646.70 | |
| Fixed Assets Annual | 2420.60 | 2296.60 | 2302.90 | 2229.30 | 2092.30 | |
| Total Non Current Assets Annual | 3143.60 | 2893.20 | 2799.80 | 2591.50 | 2406.80 | |
| Total Current Assets Annual | 3410.40 | 2494.70 | 2178.20 | 2161.00 | 2239.90 | |
| Total Assets Annual | 6554.00 | 5387.90 | 4978.00 | 4752.50 | 4646.70 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 55.00 | 52.30 | 42.80 | 98.80 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1196.40 | 784.40 | 57.70 | 183.50 | 422.50 | |
| Cash from Investing Activity Annual | -960.50 | -436.60 | -92.50 | -3.20 | -165.00 | |
| Cash from Financing Annual Activity | -237.30 | -346.80 | 35.60 | -183.10 | -261.10 | |
| Net Cash Flow Annual | - | 1.00 | 0.80 | -2.80 | -3.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 312.42 | 257.64 | 229.69 | 224.17 | 212.61 | |
| ROE Annual % | 23.36 | 13.54 | 3.31 | 7.56 | 12.26 | |
| ROCE Annual % | 27.69 | 16.17 | 3.91 | 9.52 | 15.14 | |
| Total Debt to Total Equity Annual | 0.06 | 0.03 | 0.09 | 0.06 | 0.08 | |
| EBDIT Annual Margin % | 48.80 | 39.56 | 17.40 | 31.36 | 39.20 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1110.30 | 795.60 | 1060.80 | 1160.20 | 926.90 | 513.30 | 452.60 | 918.90 | 610.60 | 590.70 | 415.20 | |
| Operating Expenses Qtr | 571.00 | 490.50 | 573.40 | 612.50 | 558.80 | 386.60 | 336.80 | 489.30 | 615.40 | 458.70 | 306.70 | |
| Operating Profit Qtr | 497.30 | 268.10 | 458.00 | 528.00 | 339.10 | 105.90 | 95.30 | 395.30 | -18.60 | 101.80 | 70.50 | |
| EBIDT Qtr Cr | 539.30 | 305.10 | 487.40 | 547.70 | 368.10 | 126.70 | 115.80 | 429.60 | -4.80 | 132.00 | 108.50 | |
| Depreciation Qtr | 55.50 | 44.20 | 43.60 | 43.50 | 41.00 | 41.50 | 41.70 | 39.60 | 38.10 | 36.00 | 34.70 | |
| Net Profit Qtr | 386.30 | 212.70 | 369.00 | 420.30 | 275.80 | 62.30 | 56.80 | 320.40 | -50.50 | 80.40 | 65.10 | |
| Basic EPS Qtr | 21.56 | 11.88 | 20.60 | 23.26 | 15.11 | 3.41 | 3.11 | 17.55 | -2.77 | 4.41 | 3.57 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4126.90 | 2811.70 | 2043.80 | 2155.70 | 2022.40 | |
| Operating Expenses Annual Cr | 2247.40 | 1771.50 | 1681.30 | 1445.90 | 1332.40 | |
| Operating Profit Annual | 1751.40 | 935.60 | 263.50 | 606.20 | 582.60 | |
| Operating Profit Margin Annual % | 42.44 | 33.28 | 12.89 | 28.12 | 28.81 | |
| Total Expenses Annual Cr | 2453.40 | 1949.80 | 1841.60 | 1576.10 | 1453.70 | |
| EBIDT Annual Cr | 1879.50 | 1040.20 | 362.50 | 709.80 | 690.00 | |
| EBIDT Annual margin % | 45.54 | 37.00 | 17.74 | 32.93 | 34.12 | |
| Depreciation | 186.80 | 163.80 | 142.60 | 116.90 | 99.80 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1388.30 | 715.30 | 170.00 | 442.40 | 458.10 | |
| Net Profit Annual | 1388.30 | 715.30 | 170.00 | 440.90 | 460.80 | |
| Basic EPS Annual | 77.34 | 39.18 | 9.32 | 24.16 | 25.26 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 5853.10 | 4873.80 | 4263.60 | 4121.60 | 3773.50 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 1.80 | 11.20 | |
| Total Non Current Liabilities Annual Cr | 80.40 | 100.50 | 135.10 | 142.90 | 117.80 | |
| Total Current Liabilities Annual Cr | 972.80 | 683.10 | 710.40 | 525.60 | 685.30 | |
| Total Capital Plus Liabilities Annual Cr | 6906.30 | 5657.40 | 5109.10 | 4791.90 | 4587.80 | |
| Fixed Assets Annual | 2572.10 | 2436.00 | 2390.60 | 2246.60 | 2102.40 | |
| Total Non Current Assets Annual | 2882.80 | 2657.10 | 2611.90 | 2454.60 | 2262.20 | |
| Total Current Assets Annual | 4023.50 | 3000.30 | 2497.20 | 2337.30 | 2325.60 | |
| Total Assets Annual | 6906.30 | 5657.40 | 5109.10 | 4791.90 | 4587.80 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 22.10 | 22.40 | 28.00 | 98.80 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1211.60 | 849.10 | 46.50 | 298.80 | 417.30 | |
| Cash from Investing Activity Annual | -1032.70 | -477.10 | -5.30 | -103.30 | -167.00 | |
| Cash from Financing Annual Activity | -246.90 | -363.00 | 34.80 | -185.70 | -250.80 | |
| Net Cash Flow Annual | - | 9.00 | 76.00 | 9.80 | -0.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 326.99 | 267.06 | 233.62 | 225.94 | 207.95 | |
| ROE Annual % | 23.71 | 14.67 | 3.98 | 10.69 | 12.21 | |
| ROCE Annual % | 28.52 | 17.61 | 4.99 | 13.89 | 15.12 | |
| Total Debt to Total Equity Annual | 0.06 | 0.03 | 0.09 | 0.06 | 0.08 | |
| EBDIT Annual Margin % | 47.00 | 38.42 | 18.63 | 34.58 | 36.03 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Vistra ITCL India Limited A/c Neelima Nannapanenni Trust | 2.28 | 74517984 | 0 | 0 |
| AKASH BHANSHALI | 1.01 | 74518007 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| V C NANNAPANENI | 15.66 | 74517966 | 0 | 0 |
| VENKATA SATYA SWATHI KANTAMANI | 8.92 | 74517967 | 0 | 0 |
| DURGA DEVI NANNAPANENI | 1.98 | 74517968 | 0 | 0 |
| RAJEEV NANNAPANENI | 0.63 | 74517969 | 0 | 0 |
| TIME CAP PHARMA LABS PRIVATE LIMITED | 9.59 | 74517982 | 0 | 0 |
| NATSOFT INFORMATION SYSTEMS PVT LTD | 8.81 | 74517983 | 0 | 0 |
| Vistra ITCL India Limited A/c Neelima Nannapanenni Trust | 2.28 | 74517984 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| MIRAE ASSET LARGE & MIDCAP FUND | 2.19 | 74517992 |
| BELGRAVE INVESTMENT FUND | 1.92 | 74517999 |
| LIFE INSURANCE CORPORATION OF INDIA - P & GS Fund | 3.86 | 74517994 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| AKASH BHANSHALI | 1.01 | 74518007 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 26, 2024 | 1.25 | INTERIM | Feb 26, 2024 | Equity Share |
| Nov 24, 2023 | 1.25 | INTERIM | Nov 24, 2023 | Equity Share |
| Aug 22, 2023 | 7 | INTERIM | Aug 22, 2023 | Equity Share |
| Feb 21, 2023 | 1.25 | INTERIM | Feb 21, 2023 | Equity Share |
| Nov 21, 2022 | 0.75 | INTERIM | Nov 22, 2022 | Equity Share |
| Aug 19, 2022 | 3.5 | INTERIM | Aug 22, 2022 | Equity Share |
| Feb 24, 2022 | 2 | INTERIM | Feb 25, 2022 | Equity Share |
| Nov 23, 2021 | 0.5 | INTERIM | Nov 24, 2021 | Equity Share |
| Aug 24, 2021 | 2 | INTERIM | Aug 25, 2021 | Equity Share |
| Feb 22, 2021 | 1 | INTERIM | Feb 23, 2021 | Equity Share |
| Nov 24, 2020 | 3 | INTERIM | Nov 25, 2020 | Equity Share |
| Aug 21, 2020 | 1.25 | INTERIM | Aug 24, 2020 | Equity Share |
| Jun 26, 2020 | 1 | INTERIM | Jun 29, 2020 | Equity Share |
| Feb 24, 2020 | 3.5 | INTERIM | Feb 25, 2020 | Equity Share |
| Nov 21, 2019 | 1 | INTERIM | Nov 22, 2019 | Equity Share |
| Aug 22, 2019 | 1.25 | INTERIM | Aug 23, 2019 | Equity Share |
| Jun 06, 2019 | 1.25 | INTERIM | Jun 07, 2019 | Equity Share |
| Feb 21, 2019 | 3.5 | INTERIM | Feb 22, 2019 | Equity Share |
| Aug 20, 2018 | 1.5 | INTERIM | Aug 21, 2018 | Equity Share |
| Feb 15, 2018 | 7 | INTERIM | Feb 17, 2018 | Equity Share |
| Aug 16, 2017 | 1.25 | INTERIM | Aug 18, 2017 | Equity Share |
| Feb 23, 2017 | 6 | INTERIM | Feb 27, 2017 | Equity Share |
| Aug 19, 2016 | 0.75 | INTERIM | Aug 22, 2016 | Equity Share |
| Feb 22, 2016 | 1.25 | INTERIM | Feb 23, 2016 | Equity Share |
| Feb 24, 2015 | 5 | INTERIM | Feb 25, 2015 | Equity Share |
| Feb 24, 2014 | 5 | INTERIM | Feb 25, 2014 | Equity Share |
| Feb 22, 2013 | 4 | INTERIM | Feb 25, 2013 | Equity Share |
| Feb 22, 2012 | 3 | INTERIM | Feb 23, 2012 | Equity Share |
| Feb 24, 2011 | 2 | INTERIM | Feb 25, 2011 | Equity Share |
| Feb 05, 2010 | 2 | INTERIM | Feb 08, 2010 | Equity Share |
| Jun 04, 2009 | 1.25 | INTERIM | Jun 05, 2009 | Equity Share |
| Nov 12, 2007 | 1.25 | INTERIM | Nov 13, 2007 | Equity Share |
| Nov 10, 2006 | 1.25 | INTERIM | Nov 13, 2006 | Equity Share |
| Nov 10, 2005 | 1.25 | INTERIM | Nov 11, 2005 | Equity Share |
| Sep 24, 2002 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Nov 26, 2015 | 10:2 | - |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 27, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 14, 2023 | Quarterly Results & Interim Dividend | - |
| Aug 09, 2023 | Quarterly Results & Interim Dividend | - |
| May 29, 2023 | Audited Results | - |
| Mar 08, 2023 | Buy Back of shares | - |
| Feb 09, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 10, 2022 | Quarterly Results & 2nd Interim Dividend | - |
| Aug 09, 2022 | Quarterly Results & Interim Dividend | - |
| May 30, 2022 | Audited Results | - |
| Feb 14, 2022 | Quarterly Results & 3rd Interim Dividend | - |
| Nov 11, 2021 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2021 | Quarterly Results & Interim Dividend | - |
| Jun 17, 2021 | Audited Results & Interim Dividend | - |
| Feb 11, 2021 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2020 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2020 | Quarterly Results & Interim Dividend | - |
| Jun 17, 2020 | Audited Results & 4th Interim Divided | Fourth Interim Divided for year ended 31.03.2020 |
| Feb 12, 2020 | Quarterly Results & 3rd Interim Dividend | - |
| Nov 12, 2019 | Quarterly Results & Interim Dividend | - |
| Aug 09, 2019 | Quarterly Results & Interim Dividend | - |
| May 27, 2019 | Audited Results & Interim Dividend | - |
| Feb 12, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 05, 2018 | Quarterly Results & Buy Back of Shares | - |
| Aug 08, 2018 | Unaudited Fin Results & Interim Dividend | - |
| May 23, 2018 | Audited Results | - |
| Feb 06, 2018 | Quarterly Results & Interim Dividend | - |
| Dec 11, 2017 | Others | - |
| Nov 02, 2017 | Quarterly Results & Others | Approval for raising of funds through further issue of shares or convertible securities of any nature through one or more modes. |
| Aug 07, 2017 | Quarterly Results & Interim Dividend | - |
| May 30, 2017 | Audited Results | - |
| Feb 14, 2017 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2016 | Quarterly Results | - |
| Aug 09, 2016 | Quarterly Results & Interim Dividend | Consideration of Employee Stock Option Scheme (NATS0P2016) under SEBI (Share Based Employee Benefits) Regulations, 2014 |
| May 26, 2016 | Audited Results | - |
| Mar 30, 2016 | Others | Approved the sale of Save Mart Pharmacy Stores located in USA which is a non-core business of the Company. |
| Feb 11, 2016 | Quarterly Results & Interim Dividend | Interim CFO Mr. S V V N Appa Rao appointed as Chief Financial Officer of the Company. |
| Nov 13, 2015 | Quarterly Results & Others | To fix record date for Sub-Division of 1 (One) Equity Share of face value of Rs.10/- each into 5 (Five) Equity Shares of Rs. 2/- Each. |
| Sep 10, 2015 | Scheme of Amalgamation & Others | 1. Approved the Preliminary Placement Document (PPD) for issue of equity shares. 2. Authorised the Committee of Directors for closing of the issue. |
| Aug 12, 2015 | Quarterly Results & Others | Board granted 1,50,000 (one lakh fifty thousand) options to eligible employees under NATSOP2015 keeping in view the SEBI (Share Based Employee Benefits) Regulations, 2014. |
| May 22, 2015 | Audited Results & Others | 1. Consideration of Employee Stock Option Scheme under SEBI (Share Based Employee Benefits) Regulations, 2014. 2. Approval of increase of equity investment percentage in the Company to 49%. |
| Feb 11, 2015 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2014 | Quarterly Results | - |
| Aug 12, 2014 | Quarterly Results & Others | convening of 31st Annual General Meeting and related matters etc. |
| May 29, 2014 | Audited Results | - |
| Feb 13, 2014 | Quarterly Results & Interim Dividend | - |
| Nov 14, 2013 | Quarterly Results | - |
| Oct 19, 2013 | Issue of Equity Shares | To consider the proposal to issue equity shares of the Company on preferential allotment basis and related matters. |
| Aug 14, 2013 | Quarterly Results | - |
| Jun 06, 2013 | Audited Consolidated Financial Results | - |
| May 30, 2013 | Audited Results | - |
| Feb 13, 2013 | Quarterly Results & Interim Dividend | - |
| Nov 08, 2012 | Quarterly Results | - |
| Aug 11, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results | - |
| Feb 09, 2012 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2011 | Quarterly Results | - |
| Aug 12, 2011 | Quarterly Results & Others | - |
| May 30, 2011 | Audited Results | - |
| Feb 14, 2011 | Quarterly Results & Interim Dividend | - |
| Nov 15, 2010 | Quarterly Results | - |
| Jul 31, 2010 | Quarterly Results & ESOP | To issue of Shares to the Employees of the Company under Employee Stock Option Scheme & to convene 27th Annual General Meeting of the Company to be held on September 30, 2010. |
| Jun 25, 2010 | Audited Results | - |
| Apr 19, 2010 | To convene an EGM of the Company | To convene an EGM of the members of the Company to be held on May 18, 2010 for consideration in Authorised Share Capital, Amendment to the Memorandum and Articles of Association. |
| Jan 27, 2010 | Quarterly Results & Interim Dividend | - |
| Oct 29, 2009 | Quarterly Results | - |
| Jul 30, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results | - |
| May 25, 2009 | Interim Dividend | - |
| Jan 27, 2009 | Quarterly Results | - |
| Oct 31, 2008 | Quarterly Results | - |
| Jul 31, 2008 | Quarterly Results | - |
| Jun 30, 2008 | Audited Results | - |
| Jan 25, 2008 | Employees Stock Option Plan | - |
| Oct 25, 2007 | Quarterly Results & Interim Dividend | - |
| Jul 26, 2007 | Quarterly Results | - |
| Jun 29, 2007 | Audited Results | - |
| Jan 30, 2007 | Quarterly Results | - |
| Oct 26, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results & Buy Back | - |
| Jun 29, 2006 | Accounts | - |
| Jan 28, 2006 | Quarterly Results | - |
| Oct 24, 2005 | Quarterly Results & Interim Dividend | - |
| Jul 30, 2005 | Quarterly Results | - |
| Jun 30, 2005 | Accounts | - |
| Apr 28, 2005 | General | - |
| Jan 29, 2005 | Quarterly Results | - |
| Oct 30, 2004 | Quarterly Results | - |
| Jul 23, 2004 | Quarterly Results & Others | Issue of Foreign Currency Convertible Bonds & Employees Stock Option Plan |
| Jun 30, 2004 | Accounts | - |
| Jan 31, 2004 | Quarterly Results | - |
| Oct 18, 2003 | Quarterly Results & Others | Allotment of equity shares on conversion of shares warrantsissued on preferential basis. |
| Jul 31, 2003 | Quarterly Results | - |
| Jun 30, 2003 | Accounts | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 28, 2002 | Quarterly Results | - |
| Jul 06, 2002 | Accounts & Quarterly Results | (Revised) |
| Apr 30, 2002 | Quarterly Results & Othes | Quarterly Results & Allotment of share warrants |
| Mar 30, 2002 | To convene EGM | - |
| Jan 29, 2002 | Quarterly Results | - |
| Oct 16, 2001 | Accounts & Quarterly Results | - |
| Jul 30, 2001 | Quarterly Results | - |
| Apr 28, 2001 | Quarterly Results | - |
| Feb 01, 2001 | Quarterly Results | - |
| Jan 31, 2001 | Quarterly Results & Preferential Offer | - |
| Jul 08, 2000 | Quarterly Results | - |
| Jun 05, 2000 | EGM | - |
| Apr 29, 2000 | Quarterly Results | - |
| Jan 31, 2000 | Quarterly Results | - |
| Oct 30, 1999 | Quarterly Results | - |
| Jul 31, 1999 | Quarterly Results | - |
| Apr 30, 1999 | Quarterly Results | - |
| Jan 30, 1999 | Quarterly Results | - |
| Oct 31, 1998 | Quarterly Results | - |
| May 28, 1998 | Half Yearly Results | - |
| Feb 28, 1998 | Half Yearly Results (Revised) | - |
| Feb 25, 1998 | Accounts & Dividend | - |
| Oct 04, 1997 | Half Yearly Results. | - |
| May 31, 1997 | Half Yearly Results. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investors Meet
01 Jul 2024
NATCO PHARMA LTD. - 524816 - Reply To The Clarification Sought On News Item
Reply to the clarification sought on news item
01 Jul 2024
NATCO PHARMA LTD. - 524816 - Clarification sought from Natco Pharma Ltd
The Exchange has sought clarification from Natco Pharma Ltd on July 1, 2024, with reference to news appeared in The Hindu Business line dated July 1, 2024 quoting "Natco Pharma mulling acquisition in RoW market to strengthen base business " The reply is awaited.
28 Jun 2024
Natco Pharma mulling acquisition in RoW market to strengthen base business
Hyderabad-based Natco has been taking steps to expand its reach and recently invested approximately $2 million in Cellogen Therapeutics Private Ltd,a Delhi based biotech start-up
26 Jun 2024
NATCO PHARMA LTD. - 524816 - Closure of Trading Window
Closure of Trading Window for the quarter ending June 30, 2024
13 Jun 2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Mr. K M V Narayana Rao as Vice President - ARD of the Company with effect from 12th June, 2024
04 Jun 2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors meet
04 Jun 2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation
04 Jun 2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript for the Earnings call held on 28th May, 2024 
